{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:55:55Z","timestamp":1791579355528,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hrthm.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:26:42Z","timestamp":1720657602000},"page":"192-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Electrophysiologic and cardiovascular manifestations of Duchenne and Becker muscular dystrophies"],"prefix":"10.1016","volume":"22","author":[{"given":"Matthew","family":"Hakimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim W.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.07.008_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13018-022-02996-8","article-title":"Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis","volume":"17","author":"Salari","year":"2022","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.hrthm.2024.07.008_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2024.07.008_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13395-018-0177-7","article-title":"Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers","volume":"8","author":"Houang","year":"2018","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.hrthm.2024.07.008_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s43440-020-00134-x","article-title":"Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future","volume":"72","author":"\u0141oboda","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.hrthm.2024.07.008_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.nmd.2017.06.557","article-title":"A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: implications of early diagnosis","volume":"27","author":"Takeuchi","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"suppl","key":"10.1016\/j.hrthm.2024.07.008_bib6","first-page":"S259","article-title":"Genetics and muscle pathology in the diagnosis of muscular dystrophies: an update","volume":"65","author":"Narasimhaiah","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mus.880121209","article-title":"Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders","volume":"12","author":"Uchino","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2024.07.008_bib8","first-page":"121","article-title":"Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","article-title":"Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis","volume":"35","author":"Landfeldt","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nmd.2019.05.003","article-title":"Inflammation-induced fibrosis in skeletal muscle of female carriers of Duchenne muscular dystrophy","volume":"29","author":"Preu\u00dfe","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2024.07.008_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","article-title":"Female dystrophinopathy: review of current literature","volume":"28","author":"Ishizaki","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2024.07.008_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","article-title":"Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies","volume":"275","author":"Politano","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.07.008_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ehjci\/jev161","article-title":"Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study","volume":"17","author":"Florian","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2024.07.008_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/mus.25445","article-title":"Cardiac involvement in female carriers of Duchenne or Becker muscular dystrophy","volume":"55","author":"Mccaffrey","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2024.07.008_bib16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3389\/fphys.2018.01770","article-title":"Identification of cardiomyopathy-associated circulating miRNA biomarkers in muscular dystrophy female carriers using a complementary cardiac imaging and plasma profiling approach","volume":"9","author":"Florian","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","article-title":"Cardiac involvement in Duchenne and Becker muscular dystrophy","volume":"7","author":"Mavrogeni","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib18","first-page":"179","article-title":"Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies","volume":"39","author":"Hoffman","year":"2020","journal-title":"Acta Myol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4330\/wjc.v8.i6.356","article-title":"Cardiomyopathy in Becker muscular dystrophy: overview","volume":"8","author":"Ho","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13023-022-02346-1","article-title":"Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases","volume":"17","author":"Del Rio\u2013Pertuz","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.07.008_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/mus.28072","article-title":"Cardiac atrial pathology in Duchenne muscular dystrophy","volume":"69","author":"Greiner","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2024.07.008_bib24","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","article-title":"Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy","volume":"112","author":"Jefferies","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.008_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10072-018-3555-3","article-title":"Clinical management of Duchenne muscular dystrophy: the state of the art","volume":"39","author":"Messina","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.hrthm.2024.07.008_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/dmcn.14129","article-title":"A new era in the management of Duchenne muscular dystrophy","volume":"61","author":"Korinthenberg","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/qjmed\/hcm124","article-title":"Cardiac involvement in muscular dystrophies","volume":"101","author":"Beynon","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.hrthm.2024.07.008_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1474-4422(14)70326-6","article-title":"Prevention of cardiomyopathy in Duchenne muscular dystrophy","volume":"14","author":"Angelini","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2024.07.008_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amjcard.2008.08.064","article-title":"Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy","volume":"103","author":"Thrush","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finsterer","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2024.07.008_bib35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mhj.2001.114804","article-title":"Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function","volume":"141","author":"Lanza","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2024.07.008_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00246-018-1881-0","article-title":"Heart rate variability and cardiopulmonary dysfunction in patients with Duchenne muscular dystrophy: a systematic review","volume":"39","author":"da Silva","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00246-014-1050-z","article-title":"Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?","volume":"36","author":"Thomas","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib38","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.hrthm.2022.04.022","article-title":"2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders","volume":"19","author":"Groh","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.07.008_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002620","article-title":"Ambulatory monitoring and arrhythmic outcomes in pediatric and adolescent patients with Duchenne muscular dystrophy","volume":"5","author":"Villa","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.07.008_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.CIR.104.1.46","article-title":"Randomized assessment of syncope trial","volume":"104","author":"Krahn","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.008_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2011.10.878","article-title":"Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry","volume":"59","author":"Pahl","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mus.24163","article-title":"Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"50","author":"Spurney","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2024.07.008_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.nmd.2012.06.213","article-title":"53 Effect of perindopril orodispersible on muscular function in early stage of Duchenne muscular dystrophy","volume":"22","author":"Duboc","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hrthm.2024.07.008_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.52.3.447","article-title":"Echocardiographic evaluation of posterior left ventricular wall motion in muscular dystrophy","volume":"52","author":"Kovick","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.008_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JND-190415","article-title":"The added value of cardiac magnetic resonance in muscular dystrophies","volume":"6","author":"Lamacie","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ppul.25227","article-title":"The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy","volume":"56","author":"Lee","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010040","article-title":"Cardiovascular measures of all-cause mortality in Duchenne muscular dystrophy","volume":"16","author":"Soslow","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2024.07.008_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-023-00922-3","article-title":"Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance","volume":"25","author":"Earl","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2024.07.008_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.008919","article-title":"Young Becker muscular dystrophy patients demonstrate fibrosis associated with abnormal left ventricular ejection fraction on cardiac magnetic resonance imaging","volume":"12","author":"Johnston","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2024.07.008_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021037","article-title":"The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy","volume":"10","author":"Henson","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.07.008_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamacardio.2016.4910","article-title":"Cardiomyopathy in muscular dystrophy: when to treat?","volume":"2","author":"McNally","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib52","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.008_bib53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne\u2019s muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JND-200556","article-title":"Mechanisms and clinical applications of glucocorticoid steroids in muscular dystrophy","volume":"8","author":"Quattrocelli","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib55","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","article-title":"All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy","volume":"61","author":"Schram","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib56","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.hrthm.2024.07.008_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JND-210776","article-title":"Comparing deflazacort and prednisone in Duchenne muscular dystrophy","volume":"9","author":"Biggar","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib58","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2024.07.008_bib59","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-8749.2010.03742.x","article-title":"Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy","volume":"52","author":"Chabrier","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archneur.62.1.128","article-title":"Intermittent prednisone therapy in Duchenne muscular dystrophy","volume":"62","author":"Beenakker","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0019-5154.44786","article-title":"Deflazacort versus other glucocorticoids: a comparison","volume":"53","author":"Nayak","year":"2008","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib62","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2024.07.008_bib63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib64","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.hrthm.2024.07.008_bib65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib66","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cardfail.2022.02.009","article-title":"2022 ACC\/AHA\/HFSA Guideline for the Management of Heart Failure: Executive Summary","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2024.07.008_bib67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jjcc.2008.08.013","article-title":"Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy","volume":"53","author":"Ogata","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.12.066","article-title":"Stem cell\u2013derived cardiomyocytes and beta-adrenergic receptor blockade in Duchenne muscular dystrophy cardiomyopathy","volume":"75","author":"Kamdar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013501","article-title":"Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial","volume":"8","author":"Raman","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.07.008_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-017-0590-8","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial","volume":"12","author":"Raman","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"suppl 2","key":"10.1016\/j.hrthm.2024.07.008_bib72","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/CRD.0000000000000305","article-title":"Proarrhythmic manifestations of neuromuscular dystrophinopathies","volume":"29","author":"Catanzaro","year":"2021","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.hrthm.2024.07.008_bib74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp.45.5.461","article-title":"A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy","volume":"45","author":"Finlay","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.hrthm.2024.07.008_bib75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","author":"Kwieci\u0144ski","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.hrthm.2024.07.008_bib76","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0167-5273(96)02620-4","article-title":"Ventricular tachycardia in Duchenne\u2019s muscular dystrophy","volume":"54","author":"Mu\u00f1oz","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib77","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1536\/ihj.16-044","article-title":"A case of refractory heart failure in Becker muscular dystrophy improved with corticosteroid therapy","volume":"57","author":"Nakamura","year":"2016","journal-title":"Int Heart J"},{"key":"10.1016\/j.hrthm.2024.07.008_bib78","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.07.008_bib79","doi-asserted-by":"crossref","first-page":"E866","DOI":"10.1212\/WNL.0000000000006950","article-title":"Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial","volume":"92","author":"Taylor","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2024.07.008_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JND-180351","article-title":"Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy","volume":"6","author":"Khan","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib81","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JND-210643","article-title":"Open-label evaluation of eteplirsen in patients with Duchenne muscular dystrophy amenable to exon 51 skipping: PROMOVI trial","volume":"8","author":"McDonald","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.hrthm.2024.07.008_bib82","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1111\/jcmm.15319","article-title":"Effect of Ataluren on dystrophin mutations","volume":"24","author":"Berger","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib83","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.hrthm.2024.07.008_bib84","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.healun.2020.01.857","article-title":"Long-term outcome of LVAD in Duchenne population with end stage cardiomyopathy","volume":"39","author":"Adorisio","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hrthm.2024.07.008_bib85","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijcard.2016.08.040","article-title":"Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: safety and risks","volume":"222","author":"Fayssoil","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib86","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.hrthm.2010.04.033","article-title":"HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy","volume":"7","author":"Lampert","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.07.008_bib87","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1540-8167.1998.tb00949.x","article-title":"Becker muscular dystrophy with bundle branch reentry ventricular tachycardia","volume":"9","author":"Negri","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4070\/kcj.2013.43.2.115","article-title":"Catheter ablation of multiple accessory pathways in Duchenne muscular dystrophy","volume":"43","author":"Finsterer","year":"2013","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2024.07.008_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00059-008-3023-6","article-title":"Wolff-Parkinson-White syndrome as initial manifestation of Becker muscular dystrophy","volume":"33","author":"Finsterer","year":"2008","journal-title":"Herz"},{"key":"10.1016\/j.hrthm.2024.07.008_bib90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the treatment preferences of seriously ill patients","volume":"346","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib91","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archinte.166.8.890","article-title":"Prospective study of health status preferences and changes in preferences over time in older adults","volume":"166","author":"Fried","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib92","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-141-11-200412070-00006","article-title":"Management of implantable cardioverter defibrillators in end-of-life care","volume":"141","author":"Goldstein","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib93","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1540-8159.2000.tb00877.x","article-title":"Patients\u2019 attitudes toward implanted defibrillator shocks","volume":"23","author":"Ahmad","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2024.07.008_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11606-007-0239-8","article-title":"\u201cThat\u2019s like an act of suicide\u201d patients\u2019 attitudes toward deactivation of implantable defibrillators","volume":"23","author":"Goldstein","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib95","first-page":"415","article-title":"Withdrawal of cardiac medications and devices","volume":"18","author":"Wiegand","year":"2007","journal-title":"AACN Adv Crit Care"},{"key":"10.1016\/j.hrthm.2024.07.008_bib96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/104990910502200305","article-title":"Letter to the editor","volume":"22","author":"Grassman","year":"2005","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.hrthm.2024.07.008_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A systematic review and meta-analysis on the epidemiology of the muscular dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.hrthm.2024.07.008_bib98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-08-045031-5.00012-8","article-title":"Emery-Dreifuss muscular dystrophy","volume":"101","author":"Puckelwartz","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib99","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng1294-323","article-title":"Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy","volume":"8","author":"Bione","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2024.07.008_bib100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2024.07.008_bib101","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mus.26782","article-title":"Emery-Dreifuss muscular dystrophy","volume":"61","author":"Heller","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hrthm.2024.07.008_bib102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J","article-title":"Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A\/C gene","volume":"48","author":"Bonne","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hrthm.2024.07.008_bib103","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.STR.0000064322.47667.49","article-title":"Clinical relevance of atrial fibrillation\/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study","volume":"34","author":"Boriani","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2024.07.008_bib104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.008_bib105","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1093\/eurheartj\/ehad561","article-title":"Emery-Dreifuss muscular dystrophy type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure","volume":"44","author":"Cannie","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.07.008_bib106","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.hrthm.2024.07.008_bib107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases","volume":"19","author":"Wilde","year":"2022","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.hrthm.2024.07.008_bib108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T09:01:12Z","timestamp":1735808472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124028820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1547527124028820"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.008","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiologic and cardiovascular manifestations of Duchenne and Becker muscular dystrophies","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}